Get started
Author

Caroline Delette

Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers
2018 · Sylvain P. Chantepie, Sylvain Garciaz, et al. · American Journal of Hematology · 45
PDF
The Warburg Effect as a Type B Lactic Acidosis in a Patient With Acute Myeloid Leukemia: A Diagnostic Challenge for Clinicians
2018 · Clément Brault, Yoann Zerbib, et al. · Frontiers in Oncology · 29
PDF
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines
2024 · Cédric Rossi, Guillaume Manson, et al. · European Journal of Cancer · 26
PDF
Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes
2016 · Virginie Chesnais, Marie-Laure Arcangeli, et al. · Blood · 26
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
2020 · Thomas Hueso, Thomas Gastinne, et al. · Bone Marrow Transplantation · 24
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study
2023 · Juliette Pénichoux, Hélène Lanic, et al. · Annals of Hematology · 17
PDF
Accurate classification of plasma cell dyscrasias is achieved by combining artificial intelligence and flow cytometry
2021 · Valentin Clichet, Véronique Harrivel, et al. · British Journal of Haematology · 15
Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report
2020 · Rémy Nyga, Caroline Delette, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study
2024 · Caroline Dartigeas, Anne Quinquenel, et al. · Annals of Hematology · 9
PDF
The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
2019 · Rémy Nyga, Laura Simon, et al. · Critical Care · 9
PDF
Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30
2020 · Lydia Montes, Estelle Tredez, et al. · Clinical Case Reports · 7
PDF
The Importance of an In-depth Study of Immunoglobulin Gene Rearrangements When Ascertaining the Clonal Relationship between Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma
2016 · Stéphanie Trudel, Hussein Ghamlouch, et al. · Frontiers in Immunology · 7
PDF
Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers
2016 · Sylvain Chantepie, Emmanuelle Tchernonog, et al. · Blood · 7
Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study
2025 · Olivier Tournilhac, Kamal Bouabdallah, et al. · Blood Advances · 6
PDF
Onsets of progression and second treatment determine survival of patients with symptomatic Waldenström macroglobulinemia
2018 · Stephanie Guidez, Julien Labreuche, et al. · Blood Advances · 5
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
2022 · Olivier Tournilhac, Solene Lecolant, et al. · Blood · 4
Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL
2022 · Guillaume Couillez, Pierre Morel, et al. · Blood Advances · 4
PDF
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
2022 · Domitille Costes-Tertrais, Thomas Hueso, et al. · Bone Marrow Transplantation · 4
Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
2020 · Olivier Tournilhac, Maya Hacini, et al. · Blood · 4
Large B-cell lymphoma: The LYSA pragmatic guidelines
2025 · Pierre Sesques, Guillaume Manson, et al. · European Journal of Cancer · 3
PDF
The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study
2022 · David Sibon, Laurence Lamant, et al. · Blood · 3
Immunomodulation with Azacytidine and Donor Lymphocyte Infusion Following Sequential Conditioning Allogenic Stem Cell Transplantation Improves Outcome of Unfavorable AML
2019 · Magalie Joris, Delphine Lebon, et al. · Blood · 3
Brigatinib in patients with ALK‐positive anaplastic large cell lymphoma who have failed brentuximab vedotin
2023 · L. Veleanu, B. Tesson, et al. · Hematological Oncology · 2
PDF
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma
2022 · Louise Bouard, Benoit Tessoulin, et al. · Haematologica · 2
PDF
A Phase II Lysa Study of Obinutuzumab Combined with Lenalidomide for Advanced Untretated Follicular B-Cell Lymphoma in Need of Systemic Therapy
2018 · Franck Morschhauser, Gilles Andre Salles, et al. · Blood · 2
Works count: 40
Citation count: 278
H-index: 9
I10-index: 8
Year
Topic
Type